322 4 BacteriaasHumanPathogens
oftheVenerealDiseaseResearchLaboratory(USA)andisknownasthe
VDRLflocculationreaction.
&Antitreponemaantibodies.ProbablydirectedatT.pallidum.
— Treponemapallidumparticleagglutination(TP-PA).Thistestformathas
widelyreplacedtheTreponemapallidumhemagglutinationassay(TPHA).
Theantigens(ultrasonically-treatedsuspensionofTreponemapallidum,
Nicholsstrain,culturedinrabbittesticles)arecoupledtoparticlesor
erythrocytes.
— Immunofluorescencetest(FTA-ABS).Inthisfluorescencetreponemal
antibodyabsorptiontesttheantigenconsistsofkilledNicholsstrain
treponemesmountedonslidesandcoatedwithpatientserum.Bound
antibodiesare detectedbymeans offluorescein-markedantihuman
IgGantibodies.SelectiveantitreponemeIgMantibodiescanbeassayed
(= 1 9S-FTA-ABS)usingantihumanIgMantibodies(lcapturetest).
— Treponemapallidumimmobilizationtest(TPItest).Livingtreponemes
(Nicholsstrain)areimmobilizedbyantibodiesinthepatientserum.This
testisnolongerusedinroutinediagnostics.Itisconsideredthegold
standardforevaluationofantitreponemeantibodytests.
Theantibodytestsareusedasfollows:
— Screening:TP-PAorTPHA(qualitative).
— Primarydiagnostics:TP-PAorTPHA,VDRL,FTA-ABS(allqualitative).
— Specialdiagnostics:VDRL(quantitative); 1 9S-FTA-ABS.
TherapeuticsuccesscanbedeterminedbythequantitativeVDRLtest.Arapid
dropinreaginsindicatesanefficacioustherapy.The 1 9S-FTA-ABScanbeused
tofindanswerstospecializedquestions.Example:doesapositiveresultin
primarydiagnostictestingindicateaserologicalscarorafreshinfection?
Treponemapallidum
Fig.4. 23 Seroustransudate
frommoistmucocutaneous
primarychancre.Directim-
munofluorescence.
4
Kayser, Medical Microbiology © 2005 Thieme